Alphamab Oncology (HKG:9966)
Hong Kong · Delayed Price · Currency is HKD 8.58
+0.28 (3.37%)
Jul 18, 2025, 11:59 AM HKT
Alphamab Oncology Market Cap
Alphamab Oncology has a market cap or net worth of 7.99 billion as of July 17, 2025. Its market cap has increased by 243.42% in one year.
Market Cap
7.99B
Enterprise Value
6.51B
Revenue
681.16M
Ranking
n/a
PE Ratio
45.88
Stock Price
8.58
Market Cap Chart
Since December 12, 2019, Alphamab Oncology's market cap has decreased from 12.11B to 7.99B, a decrease of -34.05%. That is a compound annual growth rate of -7.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 259.57B |
| Hansoh Pharmaceutical Group Company | 205.13B |
| Innovent Biologics | 147.35B |
| JD Health International | 146.09B |
| Sino Biopharmaceutical | 115.18B |
| WuXi Biologics | 115.16B |
| Akeso | 113.09B |
| CSPC Pharmaceutical Group | 98.87B |